2Q Revenues: €8.1 billion (+1%)
2Q Earnings: €1.5 billion (+4%)
YTD Revenues: €15.9 billion (-1%)
YTD Earnings: €3.1 billion (flat)
Comments: Pharmaceutical sales were up 7% to €6.8 billion. Diabetes division sales were up 16% to €1.8 billion in the quarter driven by Lantus (up 16% to €1.6 billion). Genzyme sales were up 29% to €643 million, driven by the growth of Aubagio and Fabrazyme. Sanofi Pasteur sales were flat at €718 million reflecting continued gradual recovery of Pentacel, strong performance of Flu vaccines, which was offset by lower Booster vaccines sales. Consumer Healthcare sales were €816 million, up 20%.